Skip to main content
Erschienen in: Intensive Care Medicine 3/2017

10.11.2015 | Editorial

“Does this patient have…” “Is this patient at risk for infection with multidrug resistant bacteria?”

verfasst von: Cristina Vazquez Guillamet, Marin H. Kollef

Erschienen in: Intensive Care Medicine | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Excerpt

A 67-year-old woman with insulin-dependent diabetes and end-stage renal disease receiving outpatient hemodialysis has been hospitalized twice over the past 10 weeks with acute pneumonia and respiratory failure. Given her prior hospitalizations with antibiotic exposure, this patient would appear to be at increased risk for infection with potentially antibiotic-resistant bacteria. Antibiotic resistance has emerged as one of the most important determinants of outcome in patients with serious infections along with the virulence of the underlying pathogen. Antimicrobial resistance is a growing challenge in the care of critically ill patients. Escalating rates of antibiotic resistance add substantially to the morbidity, mortality, and costs of infections in the ICU setting [1]. Both Gram-positive organisms, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), and Gram-negative bacteria, including Pseudomonas aeruginosa, Acinetobacter species, and Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria have contributed to the escalating rates of multidrug resistant (MDR) bacteria accounting for infections in the ICU. …
Literatur
2.
Zurück zum Zitat Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474CrossRefPubMed
5.
6.
Zurück zum Zitat American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef
7.
Zurück zum Zitat Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH (2012) Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 54:193–198. doi:10.1093/cid/cir813 CrossRefPubMed Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH (2012) Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 54:193–198. doi:10.​1093/​cid/​cir813 CrossRefPubMed
8.
Zurück zum Zitat Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F (2012) Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 54:470–478. doi:10.1093/cid/cir840 CrossRefPubMed Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F (2012) Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 54:470–478. doi:10.​1093/​cid/​cir840 CrossRefPubMed
9.
Zurück zum Zitat Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS (2013) A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy. Clin Infect Dis 57:1373–1383. doi:10.1093/cid/cit571 CrossRefPubMed Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS (2013) A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug resistant pathogens to select initial empiric therapy. Clin Infect Dis 57:1373–1383. doi:10.​1093/​cid/​cit571 CrossRefPubMed
10.
Zurück zum Zitat Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y (2013) Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 188:985–995. doi:10.1164/rccm.201301-0079OC CrossRefPubMed Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y (2013) Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 188:985–995. doi:10.​1164/​rccm.​201301-0079OC CrossRefPubMed
11.
Zurück zum Zitat Falcone M, Russo A, Giannella M, Cangemi R, Scarpellini MG, Bertazzoni G, Alarcón JM, Taliani G, Palange P, Farcomeni A, Vestri A, Bouza E, Violi F, Venditti M (2015) Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS ONE 10(4):e0119528. doi:10.1371/journal.pone.0119528 (eCollection 2015) CrossRefPubMedPubMedCentral Falcone M, Russo A, Giannella M, Cangemi R, Scarpellini MG, Bertazzoni G, Alarcón JM, Taliani G, Palange P, Farcomeni A, Vestri A, Bouza E, Violi F, Venditti M (2015) Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia. PLoS ONE 10(4):e0119528. doi:10.​1371/​journal.​pone.​0119528 (eCollection 2015) CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Vallés J, Martin-Loeches I, Torres A, Diaz E, Seijas I, López MJ, Garro P, Castillo C, Garnacho-Montero J, Martin Mdel M, de la Torre MV, Olaechea P, Cilloniz C, Almirall J, García F, Jiménez R, Seoane E, Soriano C, Mesalles E, Posada P (2014) Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med 40(4):572–581. doi:10.1007/s00134-014-3239-2 CrossRefPubMed Vallés J, Martin-Loeches I, Torres A, Diaz E, Seijas I, López MJ, Garro P, Castillo C, Garnacho-Montero J, Martin Mdel M, de la Torre MV, Olaechea P, Cilloniz C, Almirall J, García F, Jiménez R, Seoane E, Soriano C, Mesalles E, Posada P (2014) Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med 40(4):572–581. doi:10.​1007/​s00134-014-3239-2 CrossRefPubMed
14.
Zurück zum Zitat Chalmers JD, Rother C, Salih W, Ewig S (2014) Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 58:330–339. doi:10.1093/cid/cit734 CrossRefPubMed Chalmers JD, Rother C, Salih W, Ewig S (2014) Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 58:330–339. doi:10.​1093/​cid/​cit734 CrossRefPubMed
15.
Zurück zum Zitat Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, Carratalà J (2011) Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 17:1659–1665. doi:10.1111/j.1469-0691.2011.03484.x CrossRefPubMed Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, Carratalà J (2011) Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 17:1659–1665. doi:10.​1111/​j.​1469-0691.​2011.​03484.​x CrossRefPubMed
16.
Zurück zum Zitat Sibila O, Laserna E, Maselli DJ, Fernandez JF, Mortensen EM, Anzueto A, Waterer G, Restrepo MI (2015) Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology 20(4):660–666. doi:10.1111/resp.12506 (Epub 2015 Mar 16) CrossRefPubMed Sibila O, Laserna E, Maselli DJ, Fernandez JF, Mortensen EM, Anzueto A, Waterer G, Restrepo MI (2015) Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology 20(4):660–666. doi:10.​1111/​resp.​12506 (Epub 2015 Mar 16) CrossRefPubMed
Metadaten
Titel
“Does this patient have…” “Is this patient at risk for infection with multidrug resistant bacteria?”
verfasst von
Cristina Vazquez Guillamet
Marin H. Kollef
Publikationsdatum
10.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 3/2017
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-4126-1

Weitere Artikel der Ausgabe 3/2017

Intensive Care Medicine 3/2017 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.